Bio-Path Holdings, Inc. Gains 37.13%
Tue, Oct 08, 2024 at 07:40 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) shot up at $1.19, representing a gain of 37.1%. On Tue, Oct 08, 2024, BPTH:NASDAQ touched a New 2-Week High of $1.19. The stock appeared on our News Catalysts scanner on Tue, Oct 08, 2024 at 09:52 AM in the 'BIOTECH' category. From Tue, Sep 24, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Apr 18, 2024 at $7.67 with a volume of 83M+.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Laser Photonics Corporation (LASE:NASDAQ), 83.56%
- Turbo Energy S.A. (TURB:NASDAQ), 72.33%
- Ontrak Inc. (OTRK:NASDAQ), 51.65%
- Movella Holdings Inc Com (MVLA:NASDAQ), 48.51%
- WW International, Inc. (WW:NASDAQ), 46.95%
- Palladyne AI Corp. (PDYN:NASDAQ), 46.28%
- Nature's Miracle Holding Inc. (NMHI:NASDAQ), 44.7%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 37.13%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 36.26%